Unitex Tenamyd Canada Private Limited

Unitex Tenamyd Canada Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH2006PTC162913 Incorporated 29 June 2006 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2021
₹2.34 Lakh
▼ 76% YoY
Net profit · FY 2021
₹14,025
Net margin 6%
EBITDA · FY 2021
₹19,940
EBITDA margin 8.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Unitex Tenamyd Canada Private Limited

Data last updated:

Unitex Tenamyd Canada Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Srs Pharmaceuticals Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC162913. Its GSTIN is 27AAACU9293Q1ZC (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suchet Shyamsunder Rastogi and Rajan Dubey.

Its last annual general meeting (AGM) was held on 19 August 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080.

As per the financials filed for FY 2021, the company reported a revenue of ₹2.34 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net profit of ₹14,025 (net margin 6%) and EBITDA of ₹19,940 (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 51% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239MH2006PTC162913
Registration Number 162913
Incorporation Date 29 June 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Srs Pharmaceuticals Private Limited
Compliance Status Active Compliant

Contact details

Unitex Tenamyd Canada Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Unitex Tenamyd Canada Private Limited, buy the company report.

Comprehensive company report
Unitex Tenamyd Canada Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Unitex Tenamyd Canada Private Limited

FY 2021 filings available

Unitex Tenamyd Canada Private Limited reported revenue of ₹2.34 Lakh (down 76% YoY) for FY 2021.

Revenue · FY 2021
₹2.34 Lakh ▼ 76%
Net profit · FY 2021
₹14,025 margin 6%
EBITDA · FY 2021
₹19,940 margin 8.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 76%
5 years · compounded
▲ 51%
EBITDA CAGR growth
1 year
▼ 90%
3 years · compounded
▲ 54%
5 years · compounded
▲ 17%

Revenue fell 76% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 51%. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2.34 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹19,940
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14,025
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin8.5%
Net Profit Margin6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Unitex Tenamyd Canada Private Limited, buy the company report.

Board of directors of Unitex Tenamyd Canada Private Limited

Unitex Tenamyd Canada has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Suchet Shyamsunder RastogiDirector29 Jun 200620 Years 4 MonthsCurrent
Rajan DubeyDirector06 Feb 20206 Years 9 MonthsCurrent

Peer comparison

Unitex Tenamyd Canada Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Valtin Healthcare Private Limited₹2.38 Lakh (FY 2018)New Delhi, Delhi, India
Ambrosia Wellness Private Limited₹2.38 Lakh (FY 2025)6.0%Hyderabad, Telangana, India
Life Plus Pharmaceuticals Private Limited₹2.38 Lakh (FY 2021)Mumbai, Maharashtra, India
Ritesh Health-Care Private Limited₹2.35 Lakh (FY 2022)Delhi, India
Evehica Pharmaceutical Private Limited₹2.35 Lakh (FY 2024)Ahmedabad, Gujarat, India
Unitex Tenamyd Canada Private Limitedthis company₹2.34 Lakh (FY 2021)₹14,0256%-76.0%Mumbai, Maharashtra, India
Hargo Pharm Private Limited₹2.33 Lakh (FY 2017)107.0%Thane, Maharashtra, India
Systems Bio-Medical (India) Pvt Ltd₹2.32 Lakh (FY 2025)-68.0%Mumbai, Maharashtra, India
Entod Healthcare Private Limited₹2.31 Lakh (FY 2025)12.0%Mumbai, Maharashtra, India
Srivu Life Science Private Limited₹2.3 Lakh (FY 2025)-29.0%Patna, Bihar, India
Sirsha Wellness Private Limited₹2.3 Lakh (FY 2025)Miraj, Maharashtra, India

To see the full peer comparison of Unitex Tenamyd Canada Private Limited, buy the company report.

Auditor

Unitex Tenamyd Canada Private Limited is audited by M SHETH & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
M SHETH & COFY 2021116371W

Shareholding

The shareholding of Unitex Tenamyd Canada Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Unitex Tenamyd Canada Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Unitex Tenamyd Canada Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Unitex Tenamyd Canada has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACU9293Q1ZCMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Unitex Tenamyd Canada Private Limited, buy the company report.

Recent activity

Unitex Tenamyd Canada Private Limited has 6 board changes on record since 2006: 2 appointments and 4 cessations. The latest: Rajan Dubey ceased to be Additional Director on 30 Dec 2020.

AGM
Unitex Tenamyd Canada Private Limited last Annual general meeting of members was held on 19 Aug 2021 as per latest MCA records.
Filing
Unitex Tenamyd Canada Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai I.
Ceased
Rajan Dubey ceased to be Additional Director.
Ceased
Ratnakar Pandarinath Mehendre ceased to be Director.
Appointed
Rajan Dubey was appointed as Director.
Ceased
Aman Singh Siwach ceased to be Additional Director.
Ceased
Mahika Suchet Rastogi ceased to be Director.
Appointed
Suchet Shyamsunder Rastogi was appointed as Director.
Incorporation
29 Jun 2006
Unitex Tenamyd Canada Private Limited was registered on 29 Jun 2006 with Roc Mumbai I & aged 20 years 4 months as per MCA records.

Frequently asked questions

Unitex Tenamyd Canada is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2006 (20+ years old) and is registered under CIN U24239MH2006PTC162913.

Unitex Tenamyd Canada has 2 current directors:

The latest financial statements of Unitex Tenamyd Canada on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 19 August 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Unitex Tenamyd Canada is 27AAACU9293Q1ZC, registered in Maharashtra.

The CIN (Corporate Identification Number) of Unitex Tenamyd Canada is U24239MH2006PTC162913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Unitex Tenamyd Canada was incorporated on 29 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Unitex Tenamyd Canada by revenue are Valtin Healthcare Private Limited, Ambrosia Wellness Private Limited, Life Plus Pharmaceuticals Private Limited, Ritesh Health-Care Private Limited, Evehica Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Rajan Dubey ceased to be Additional Director on 30 Dec 2020. Ratnakar Pandarinath Mehendre ceased to be Director on 31 Mar 2020. Rajan Dubey was appointed as Director on 06 Feb 2020. Unitex Tenamyd Canada has 6 board changes on record in total.

The registered office of Unitex Tenamyd Canada is at 504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080.

Unitex Tenamyd Canada operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Unitex Tenamyd Canada is compliant as of 05 September 2026. The company is actively filing with the Registrar of Companies.